Clinical Trials Logo

Clinical Trial Summary

The purpose of this four-arm randomized controlled study is to determine whether eliminating glucocorticoids (GC) replacement in perioperative period in surgical patients with sellar lesion could result in similar or better outcomes comparing to traditional replacement therapy, regarding postoperative recovery of pituitary function and other postoperative complications (infection, pain, quality of life, recurrence). Surgical patients of our center with MRI-confirmed diagnosis of sellar lesion will be enrolled, insulin tolerance test (ITT) will be performed for assessment of the pituitary function at enrollment. Patients with normal pituitary function will be randomized into non-GC replacement group (group A) and low-dose GC replacement group (group B), while patients with impaired pituitary function will be randomized into low-dose GC replacement group (group C) and high-dose GC replacement group (group D). The primary outcome is the hypothalamic-pituitary-adrenal (HPA) -axis function of the patients, evaluated by plasma cortisol and adrenocorticotropic hormone (ACTH) levels. The secondary outcomes include the hypothalamic-pituitary-thyroid (HPT) axis function (TSH, thyroid-stimulating hormone, free T3, free T4), postoperative water-electrolyte balance, infection, recurrence and health-related quality of life.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02190994
Study type Interventional
Source West China Hospital
Contact Senlin Yin, M.D.
Phone +86 13072808795
Email enforest@gmail.com
Status Recruiting
Phase Phase 4
Start date August 2013
Completion date December 2014

See also
  Status Clinical Trial Phase
Recruiting NCT02549768 - Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery Phase 4
Terminated NCT02629549 - Intraoperative Imaging of Pituitary Adenomas by OTL Phase 1
Recruiting NCT02288962 - Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas Phase 3
Terminated NCT02743442 - Da Vinci Transoral Robotic-assisted Surgery of Pituitary Gland N/A
Completed NCT02632084 - Follow-up Evaluation of Photo-Dynamic Therapy for Pituitary Tumours N/A
Not yet recruiting NCT06282224 - Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery N/A
Recruiting NCT05108064 - Radiomic and Pathomic Study of Pituitary Adenoma Using Machine Learning
Active, not recruiting NCT03665064 - Long Term Outcome Study in Patients With Pituitary Disorders
Recruiting NCT01775332 - Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools N/A
Completed NCT05088252 - Desflurane and Anesthesia Recovery Period in Endonasal Endoscopic Pituitary Adenoma Resection N/A